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Abstract
Background: Breast density is a significant breast cancer risk factor. Currently, there is no
standard method for measuring this important factor. Work presented here represents an essential
component of an ongoing project that seeks to determine the appropriate method for calibrating
(standardizing) mammography image data to account for the x-ray image acquisition influences.
Longer term goals of this project are to make accurate breast density measurements in support of
risk studies.
Methods: Logarithmic response calibration curves and effective x-ray attenuation coefficients
were measured from two full field digital mammography (FFDM) systems with breast tissue
equivalent phantom imaging and compared. Normalization methods were studied to assess the
possibility of reducing the amount of calibration data collection. The percent glandular calibration
map functional form was investigated. Spatial variations in the calibration data were used to assess
the uncertainty in the calibration application by applying error propagation analyses.
Results: Logarithmic response curves are well approximated as linear. Measured effective x-ray
attenuation coefficients are characteristic quantities independent of the imaging system and are in
agreement with those predicted numerically. Calibration data collection can be reduced by applying
a simple normalization technique. The calibration map is well approximated as linear. Intrasystem
calibration variation was on the order of four percent, which was approximately half of the
intersystem variation.
Conclusion: FFDM systems provide a quantitative output, and the calibration quantities presented
here may be used for data acquired on similar FFDM systems.
1. Background
Early detection is a key element in reducing breast cancer
mortality [1]. Mammography screening is an essential sur-
veillance component for early detection [2]. Similarly,
there is interest in developing total cancer care methods in
clinical practice so that disease screening and treatment
can be tailored to the patient [3]. The development of
accurate breast cancer risk models may play an important
role in designing risk based cancer control strategies.
Because breast density is a significant breast cancer risk
factor [4], it may be useful to include it in the clinical set-
ting for risk assessment. The Gail breast cancer risk model
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is used for intervention studies and counseling [5] but
does not include breast density beyond research purposes.
There is a critical need to incorporate all available infor-
mation on breast cancer risk to ensure that risk models are
useful for clinical decision making [6].
Mammographic density and breast density are terms used
synonymously to describe the degree of bright areas in
mammograms, which is related to dense breast tissue.
Substantial evidence indicates that women with greater
quantities of breast density have a significantly increased
breast cancer risk [7]. Breast density may be assessed from
either film mammograms or from the newer full field dig-
ital mammography (FFDM) systems. To date, most pub-
lished breast density related research is based on film
analysis without applying standardization [4,8], which
may be due to the availability of archived film data rela-
tive to FFDM data. The overall equivalence of film mam-
mography and FFDM for breast cancer detection [9] may
indicate that the FFDM system use will increase, which is
the case at this center.
Methods used for assessing breast density may be loosely
grouped into (1) techniques that do not consider the
acquisition influences, and (2) radiometric standardiza-
tion techniques that compensate for the acquisition influ-
ences. Standardization (calibration) methods are to
correct for interpatient variations in the x-ray exposure,
beam type, compression height, and the detector
response. Standardization techniques are under develop-
ment for both film [10-12] and FFDM applications [13].
To the best of our knowledge, there are no published
reports on calibrated techniques with risk assessments
using breast cancer as the endpoint. A non-calibration
user-assisted approach has been shown consistently to
produce a measure that correlates with breast cancer [4,8],
which produces a binary labeled image defining dense
and fatty tissue. However, there is no universal standard
used for measuring breast density [14].
Our previous work showed that it is possible to make
effective attenuation coefficient measurements using the
General Electric (GE) FFDM system with phantom imag-
ing [8]. In this prior work, theoretical arguments were
developed without considering the detector interaction or
specific x-ray spectral form, which predicted linear loga-
rithmic response curves. Idealized x-ray equations were
then used with simulated x-ray spectra, tabulated attenua-
tion data, and numerical integration to generate logarith-
mic response curves. These numerically generated curves
were well approximated as linear and were used to make
effective attenuation coefficient estimates, which were
then compared with measured coefficient values obtained
experimentally with phantom imaging. This work sug-
gested that the effective attenuation coefficients may be
used for calibration purposes as known quantities. This
previous work did not provide measured effective attenu-
ation coefficient values for glandular or fatty breast tissue.
Findings presented here represent essential components
of an ongoing project for developing calibration tech-
niques for FFDM breast cancer risk applications [8] that
extends earlier research [13]. This project includes meas-
uring the intra/inter system concordance of calibration
data generated with phantom imaging using two similar
FFDM systems. Serial stability comparisons will be ana-
lyzed after collecting sufficient data over an extended
period. The overall goals of this multiyear project are to
(1) determine the necessary amount of calibration data
that must be collected (sampled) to calibrate the prospec-
tive data with a given accuracy using breast cancer as the
endpoint, (2) analyze the serial stability of the systems by
sampling the calibration data, and (3) study the wider
applicability of calibration data generated on a given sys-
tem by assessing the necessary requirements to merge data
from multiple systems. The serial stability analysis is in
support of a multiyear case control study that involves col-
lecting prospective patient image/risk data. By hypothesis,
this data will be used to validate the calibration procedure
by showing that it produces a stronger risk relation when
compared with methods that do not consider the acquisi-
tion influences when applied to the same dataset.
Specifically in this report, effective attenuation coeffi-
cients and breast tissue equivalent calibration curves gen-
erated with two similar FFDM systems were compared for
the three filter\target combinations and multiple voltage
settings. This may be considered the baseline (BL) data
collection and analysis for the ongoing serial study. Effec-
tive attenuation coefficients were also compared with val-
ues generated from numerical integration by using
idealized x-ray attenuation equations. Methods for gener-
ating these quantities were described previously [8] and
will not be repeated in detail here. A technique for reduc-
ing the amount of calibration data collection was investi-
gated.
The percent glandular (PG) equivalent transform (map)
construction and functional form were investigated with a
specific acquisition example and numerical methods. In
practice, the PG map will be used to calibrate arbitrary
image data. Tissue equivalent logarithmic response curve
analyses enabled the map construction. Uncertainty in the
PG map was estimated with error propagation techniques.
2. Methods
Phantom imaging was performed at two locations with
GE Senographe 2000D FFDM systems that were manufac-
tured about the same time (spring-summer 2000). Both
systems are used for clinical breast screening. The systemsBioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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are located at the Moffitt Cancer Center, Tampa, Florida,
and the via Christy Regional Medical Center, Wichita,
Kansas, which will be referenced as the FL and KS loca-
tions, respectively. Senographe 2000D systems produces
both raw data (x-ray exposure representation) and proc-
essed data with 100 micron digital resolution and 14 bit
dynamic pixel range. Raw data was used for this work.
This system has three target\filter combinations
(described below). The system detector is described else-
where [13,15]. Phantoms used for this study were
obtained from Computerized Imaging References Systems
(CIRS, Norfolk VA). The quality of these phantoms and
their close similarity with the x-ray interaction characteris-
tics of breast tissue within the realm of mammography x-
ray spectra are discussed in previous work [8] and related
references therein. Phantoms for both locations have dif-
ferent geometries but were manufactured with the same
material specifications: 100% glandular breast tissue
equivalent and 100% fatty breast tissue equivalent. Flor-
ida phantoms are 18 cm × 24 cm rectangular slabs with
either one or two cm heights. Kansas phantoms have a
semicircular breast-like geometry with one cm heights.
Example phantom images for the FL and KS locations are
shown in Fig. 1 and Fig. 2, respectively. Kansas phantoms
are 19 cm in length along the left hand margin in the y
direction (from top to bottom), and the distance from left
hand border along the x direction to the furthest distance
to the semicircular perimeter is 13 cm.
Baseline tissue equivalent logarithmic response curves
were measured for both locations. Response curves were
generated by measuring the response for a particular
acquisition technique (for a given voltage setting, tar-
get\filter combination, and exposure) as a function of
phantom configuration height above the detector. These
response curves permit the calibration of data collected
with other acquisition techniques. Molybdenum/Molyb-
denum (Mo/Mo), Molybdenum/Rhodium (Mo/Rh), and
Rhodium/Rhodium (Rh/Rh) target\filter combinations
were used to generate the response curves. The voltage set-
ting abbreviation used here corresponds with the peak
voltage (kVp) system console indicator. Each tissue type
response curve was generated for these settings: Mo/Mo –
[26,27] kVp; Mo/Rh – [28, 29] kVp; and Rh/Rh – [30
kVp]. All BL response curves were generated with the 160
milliamp second beam-current system setting, which cor-
responds to the system console mAs indicator. The system
mAs value was used as surrogate for the incident exposure.
Phantoms were imaged either with [2–6] cm, [2–7] cm, or
with [3–7] cm heights depending on the target\filter com-
bination using one cm height increments. The 160 mAs
setting was used because it provided signal when imaging
the more attenuating [6–7] cm glandular configuration
while not saturating the intensity values for less attenuat-
ing [2–3] cm fatty phantom arrangements. All image data
was acquired as left cranial caudal views. Florida BL data
was acquired in October 2006, and KS data was acquired
in November 2006. The compression paddle was in place
and in contact with the top phantom for all configura-
tions while imaging to mimic patient imaging. The flat
field quality assurance procedure (assessed by the built-in
system diagnostics) was implemented before imaging to
ensure that the system was operating within the manufac-
turer's tolerances.
An 800 × 1400 pixel rectangular region was used for the
analysis, which defined the field of view (FOV). The aim
was to restrict the comparison analysis to the same detec-
tor regions for both systems. The FOV, which is shown in
Fig. 1 and Fig. 2, was dictated by the KS phantom geome-
try. The FOV is approximately the largest rectangle that fits
within the semicircular geometry with the left hand mar-
gin.
Logarithmic response (LR) curves were determined for
each 50 × 50 pixel sector within the FOV as a function of
phantom height and averaged for a given tissue type. Each
sector was fitted with this linear model
Rectangular phantom used in the Florida location Figure 1
Rectangular phantom used in the Florida location. 
Labeled rectangular region is the field of view defined in the 
manuscript. The phantom nearly covers the entire detector.BioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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LR(t) = -µt + l,( 1 )
where t is a given phantom configuration height meas-
ured in cm, µ is the effective x-ray attenuation coefficient
for a given tissue type measured in cm-1, and l is the loga-
rithmic intercept value (unitless) for a given tissue type.
Within a given sector, the pixel values (V) were averaged
and natural logarithm transformed. This procedure was
applied to each phantom for given height, given sector,
and then for every sector and height. Plotting ln
[mean(V)/mAs ], where mAs is the system acquisition rea-
dout, as a function of phantom height above the breast
support surface (bucky) gives the empirical LR for a given
square. The mAs  normalization is discussed below in
more detail. The sectored analysis resulted in a distribu-
tion of 16 × 28 values for each of the two model parame-
ters for each tissue type LR  curve. Findings will be
presented as the mean and standard deviation for the var-
ious distributions. Confidence intervals (CIs) were gener-
ated for the regression parameters. For one example, the
LR plot will be provided for one individual sector centered
on the detector in the y direction positioned on the left-
hand side of FOV (approximately under the focal point).
The R2 statistic was used to assess the linear model agree-
ment, because it is the fraction of variability explained by
the model (unity implies perfect agreement) and therefore
represents an important goodness of fit measure derived
from the residual analysis. The distribution of R2 coeffi-
cients was generated and summarized to assess the linear
model agreement. Effective attenuation coefficients were
derived with numerical methods discussed previously [8]
and compared with the corresponding measured values.
Previously [8] for normalization purposes, the detector
response was first measured as function of beam-current
setting and fitted to this model: V = m(mAs) + b, where m
and b are constants for a given beam-type (fixed kVp and
target\filter settings) [8]. This was achieved by acquiring
exposures of the detector (no attenuation) for mAs set-
tings up to the point of detector saturation (not including
saturation). Response curves acquired with phantom
imaging were analyzed by first transforming V  to the
equivalent mAs value for a arbitrary acquisition by invert-
ing the detector response: mAs equivalent = (V-b) m-1. The
equivalent mAs value was then normalized by the acquisi-
tion mAs and logarithmically transformed giving the log-
arithmic relative exposure relation: LRE = ln[(V - b) (mAs
× m)-1]. The response generated with the reference mAs
was then equated with the response generated for arbi-
trary mAs value giving
where the subscript indicates reference values. When V >
b, this relation reduces to
For the work below, this normalization was applied
where V  is the average sector value. When the Eq. (3)
approximation holds, the need to characterize the detec-
tor response is eliminated. Moreover, Eq. (3) suggests that
for fixed voltage setting and target\filter combination, a
response curve generated with one mAs value is equivalent
to all other curves acquired with varying mAs values. In
this work, Eq. (4) was measured as a function of phantom
height and fitted with the linear model defined in Eq. (1)
for both tissue types.
























ln[ ] ~ ln[ ], (4)
Semicircular phantom used in the Kansas location Figure 2
Semicircular phantom used in the Kansas location. 
The interior rectangle covers the same detector region as 
the field of view defined in Fig 1. Because the off phantom 
area is over exposed, the outside detector perimeter was 
labeled manually for reference.BioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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For the mAs normalization analysis, additional phantom
imaging was performed at the FL location (only) to gener-
ate the Mo/Mo – 26 kVp glandular tissue LR curves for 160
mAs and 200 mAs acquisitions to assess Eq. (3). Addi-
tional data was also acquired to generate the fatty tissue
LR curves for 160 mAs and 110 mAs for the same voltage
setting and target\filter. In this analysis, mAsr = 160. This
additional data collection was used to eliminate the pos-
sibility of serial drift influence in the normalization anal-
ysis. Mo/Mo – 26 kVp acquisition parameters are
approximately the average settings used in clinical practice
[16].
To assess the linear calibration model, the calibration pro-
cedure derived from the LR  regression parameters was
compared with the measured calibration curve for a fixed
height of 6 cm (T = 6 cm total height). For a given acqui-
sition technique, two calibration points are required [13]
to calibrate arbitrary image data. These points correspond
to the LR value for each tissue type for a given height,
which can be estimated from Eq. (1) with t = T. In practice,
the detected LR value is likely to fall between the end-
points. For fixed height and arbitrary logarithmic
response, LRa = z, the PG map is given by
PG = Mz + B.( 5 )
The validity of the linear map form is addressed in the
Appendix. The M and B parameters can be expressed as
functions of the LR regression parameters by using PG =
100% and PG = 0% as boundary conditions with Eq. (1),
which gives
M = 100 × [(µg - µf)T + (lg - lf)]-1
and
where the g and f subscripts denote glandular and fatty tis-
sue values, respectively. Equation 1 was modified to
derive Eq. (6) with this form: LR = µt + l. A sequence of five
phantom images was acquired to verify Eq. (6). This
sequence represents a surrogate composite fatty/glandular
tissue mixture for T = 6 cm corresponding to the known
[0, 16.6, 50, 83.3, 100] PG mixtures. The known PG is
determined from this relation: (height of the 100% glan-
dular tissue component)/T × 100% for a given phantom
image in the sequence. In [glandular, fatty] cm compo-
nent phantom heights, these proportions correspond to
composite heights of [0,6], [1,5], [3,3], [5,1], and [6,0],
where the two component heights within a given bracket
add to 6 cm. The sequence represents a surrogate because
the various mixtures are not present in one image but in
five separate images acquired consecutively. As a specific
example, the Mo/Mo – 26 kVp acquisition settings were
used to generate the sequence. Plotting z (see Eq. (5))
along the x axis and plotting the known PG values along
the y axis shows the map. The agreement between PG = Mz
+ B using the LR regression distribution quantities substi-
tuted into Eq. (6) was compared with the known and
measured PG determined from the surrogate composite
phantom images.
For the map analysis, LRs were generated again for [2–6]
cm heights using the same phantom imaging procedure
outlined above by acquiring another dataset not included
in the BL acquisition. This additional data collection will
show the best scenario because the data (the phantom
images for the tissue LRs and PG curves) were collected on
the same day in January 2007 to eliminate the possibility
of serial drift uncertainty. A sector example will also (the
same sector as above) be used for demonstration pur-
poses.
Variation in the map due to the uncertainty in each quan-
tity may be estimated with derivative approximations
using PG = f(µg, µf, lg, lf, z) giving
where the ∆ quantities are the estimated variation in the
respective parameters. The explicit terms for Eq. (8) are
derived in the Appendix using Eq. (6) with Eq. (7). The
height, T, is considered as exact and therefore does not
contribute. The quadratic form used in Eq. (7) assumes
each component contribution is independent. Equation
(7) was used to estimate both intersystem variability
(external variation) and intrasystem variability (internal
variation). The total variation is given by
where each term in Eq. (7) has been relabeled, respec-
tively. Intersystem analysis was used to derive the ∆ terms
for the external variation, which provided an estimate of
the uncertainty when applying the map generated at one
facility for data collected at another location. The internal
variation was estimated with the FL spatial LR analysis.
For both internal and external analyses, z and ∆z were esti-
mated for each PG surrogate component (6 cm height) as
the average and standard deviation of log-transformed
and mAs normalized FOV pixel distribution, respectively.
Although z and ∆z were estimated with FL data, they sup-
port reasonable estimates of the anticipated uncertainty
BM T l l gf g f =− × + + +
1
2
100 ([ ( ) ( ) ] ) , µµ (6)
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due to the variations in the other PG map parameters for
both uncertainty forms. The 26 kVp – Mo/Mo acquisition
was used for the uncertainty analysis.
3. Results
3. 1 Inter and intra system comparisons
Table 1 shows the regression parameter distribution sum-
mary quantities for Mo/Mo datasets. The 95% two sided
CIs for the effective attenuation coefficients and intercepts
are provided below the respective quantities for these and
the other examples. The CIs represent averages taken over
all sectors for the distribution examples. For a given tissue
type, effective x-ray attenuation coefficients are similar
between locations, whereas l values vary somewhat rela-
tive to attenuation coefficient variation. Agreement may
be gauged from the parenthetical entries and CIs. Paren-
thetical quantities listed in the attenuation coefficient and
intercept columns are absolute values of the percent dif-
ference between the location parameters. For example, the
glandular quantity was calculated as |(µgFL - µgKS)/µgKS| ×
100%, which was used for all calculations of this type. For
either location, the intrasystem variation is relatively
small for the regression parameters, which follows from
the σ and σl column entries. Glandular tissue attenuation
coefficient variation is larger than the corresponding fatty
tissue variation as indicated in the ∆ column. Signal is
attenuated greater at a given height for the glandular tissue
relative to the fatty tissue indicating there may be greater
uncertainty due to the decreased signal. The R2 statistic for
all cases is close to unity indicating agreement with the
linear model.
Variation in R2 is not provided because it was very close to
zero in all cases. Individual sector LR example plots for the
Mo/Mo – 26 kVp settings are shown in Fig. 3 (glandular)
and Fig. 4 (fatty). Plots for a given tissue type are shown
in the same figure for intersystem comparisons. In these
plots, measured points from the FL location are denoted
by diamonds and asterisks for the KS measured points.
Fitted lines from the regression analysis are solid for the
FL plots and dashed for KS plots. Regression parameters
are listed in Table 2. Regression parameter distribution
quantities for the other Mo/Rh and Rh/Rh settings are
shown in Table 3. The corresponding individual sector
plot examples for these other settings are not shown
because they were similar to the prior examples. For all
distribution examples, variation within given location is
relatively small, and the effective attenuation coefficients
are in close agreement between the locations. Moreover,
the linear model approximation holds when assessing the
R2 statistic for all situations. To show the intersystem
agreement, a paired t-test was applied by pairing all of the
10 average attenuation coefficient quantities for the FL
location with the corresponding values from the KS loca-
tion (second column from Table 1 and Table 3), which
gave p = 0.56 (linear correlation of = 0.97). Following the
same procedure for the 10 average intercept quantities
(using the fifth columns from the same tables), gave p =
Table 1: Molybdenum/Molybdenum regression distribution quantities. Quantities are summaries of the field of view: µ is the mean 
effective x-ray attenuation coefficient, σ is the standard deviation of the µ distribution, ∆ is the mean variation in µ derived from 
averaging the individual regression variation, l is the mean logarithmic intercept, σl is the standard deviation of the l distribution, and 
R2 is the mean of the associated distribution. Two sided 95% mean confidence interval is cited under the respective µ and l quantities. 
Location is indicated by the subscripts of the left hand column entries. Parenthetical FL entries indicate the absolute value percent 
difference between respective location quantities.
Mo/Mo 26 kVp µσ ∆ l σl R2
FatFL 0.572 0.001 0.005 5.093 0.010 0.998
0.557–0.586 (1.9%) 5.03–5.15 (2.6%)
FatKS 0.583 0.001 0.005 4.964 0.010 0.998
0.568–0.599 4.89–5.03
GlandFL 0.833 0.002 0.015 4.893 0.001 0.998
0.784–0.882 (0.60%) 4.68–5.10 (2.6%)
GlandKS 0.838 0.010 0.012 4.767 0.020 0.998
0.799–0.877 4.60–4.93
Mo/Mo 27 kVp µσ ∆ l σl R2
FatFL 0.559 0.001 0.005 5.262 0.010 0.999
0.544–0.575 (2.1%) 5.19–5.32 (1.8%)
FatKS 0.571 0.001 0.005 5.165 0.010 0.999
0.554–0.586 5.09–5.16
GlandFL 0.805 0.003 0.020 5.043 0.010 0.998
0.750–0.860 (0.40%) 4.81–5.28 (1.9%)
GlandKS 0.808 0.005 0.014 4.950 0.020 0.999
0.763–0.854 4.75–5.14BioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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0.101 (linear correlation = 0.99). Using the p value as a
gauge, effective attenuation coefficients as an ensemble
are similar across the two systems. Intersystem intercept
comparisons indicate a weak system dependence.
Measured attenuation coefficients were compared with
those generated with numerical methods. The resulting
figures of merit are listed in Table 4. The last column gives
the averaged intersystem measured attenuation coeffi-
cients for comparison purposes. The R2 values are also
provided for this modeling, which indicate the linear
model approximation holds in the theoretical develop-
ments as well. Numerical effective attenuation values are
listed in the µT column. The associated CIs indicate
approximate agreement with the measured values. Meas-
ured value agreement is also indicated by the parentheti-
cal percent differences cited with the respective µT values.
Intercept quantities were irrelevant.
3. 2 Response normalization
Table 5 shows the additional LR distribution parameters
generated for the mAs  response normalization analysis
using [160, 110] mAs for the fatty tissue type and [160,
200] mAs for the glandular tissue type. For each tissue
type, mAsr = 160. The quantities in Table 5 show that the
Eq. (3) approximation holds. A comparison of the respec-
tive attenuation coefficients for the varying mAs  values
indicates close agreement. This suggests the LRs acquired
for a given acquisition mAs determine the LRs for an arbi-
trary mAs readout value.
3.3 Percent glandular map
Calibration map distribution quantities derived from the
surrogate mixture phantom images are listed in the PG
row of Table 6. Internal variation in M is small relative to
the best estimate of M, spatial variations in both M and B
are relatively small, and R2 indicates the linear model
approximation holds. The bottom row of Table 6 shows
M and B estimated with Eq. (6) using the quantities from
Table 5. Deviation of the measured PG value from the
known phantom configuration is discussed below. Quan-
tities in Table 6 indicate that the measured map agrees
with the model and is well approximated as linear, as pre-
dicted by the work in the Appendix; a related numerically
generated map is shown in Fig. 5. As further demonstra-
tion, the measured map determined from the individual
sector example is shown in Fig. 6. For this case, M = -57.23
± 1.23, B = 93.93 with R2 = 0.999. Both M and B values for
the sector agree with the respective entries in Table 6.
3.4 Uncertainty analysis
Uncertainty in the PG components expressed in Eqs. (7–
8) were generated for the intersystem variation (external)
and the intrasystem (internal) variation for a Mo/Mo – 26
kVp example. External variations in the log intercepts and
attenuation values were estimated by taking the absolute
value difference between respective location quantities
from Table 1. The 160 mAs generated effective attenuation
coefficients and the log intercepts listed in Table 5 were
used as the known values for both the external and inter-
nal variation calculations. Internal variation was esti-
mated by using the 160 mAs spatial distribution values
cited in Table 5. Internal variations in the attenuation
coefficients and log intercepts were taken from the σ and
σl columns in Table 5. Estimated uncertainties for the
Glandular tissue logarithmic response sector example plots Figure 3
Glandular tissue logarithmic response sector exam-
ple plots. These plots show the example sector response 
curves for the Florida (diamonds) and Kansas (asterisks) 
locations for the 26 kVp – Mo/Mo settings. The fitted regres-
sion line is solid for Florida and dashed for Kansas.










Fatty tissue logarithmic response sector example plots (same  format as Fig. 3) Figure 4
Fatty tissue logarithmic response sector example 
plots (same format as Fig. 3).
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regression analysis parameters are summarized in Table 7.
Uncertainties are broken down into their respective com-
ponents along with the totals in Table 8, which follow
from Eqs. (7–8); z distribution quantities are cited in the
bottom rows. External variation is approximately twice
that of the internal. External logarithmic intercept differ-
ences represent major contributions, which are cited in
the n3 and n4 columns; as one component increases the
other decreases and vice versa, which maintains the varia-
tion throughout the PG  composition. Related internal
components show a similar trend but with smaller contri-
butions. If a bias exists with this specific example, it will
tend to over estimate the external variation because this
dataset has at least equivalent if not more intersystem var-
iability in comparison with the other datasets.
4. Discussion
Calibration curves are well approximated as linear, which
differs from related work that used polynomial modeling
[13]. Differences may stem from the elemental sector size
used to generate the response curves. The related work did
not sector the detector. Intersystem effective attenuation
coefficients are similar and are in agreement with the
numerically/theoretically derived values indicating that
the Senographe 2000D produces a quantitative output.
Although subject to further verification, intersystem agree-
Table 2: Molybdenum/Molybdenum individual sector example regression parameters. Labeling is analogous to Table 1 as applied to a 
single realization.
Mo/Mo 26 kVp µ∆ l R
FatFL 0.573 0.004 5.103 0.999
0.559–0.586 (2.4%) 5.05–5.16 (2.4%)
FatKS 0.587 0.005 4.99 0.999
0.573–0.600 4.92–5.04
GlandFL 0.837 0.014 4.904 0.999
0.791–0.883 (0.12%) 4.70–5.09 (2.4%)
GlandKS 0.845 0.011 4.788 0.999
0.809–0.882 4.59–4.98
Table 3: Molybdenum/Rhodium and Rhodium/Rhodium regression distribution quantities (using the same format as in Table 1).
Mo/Rh 28 kVp µσ ∆l σl R2
FatFL 0.503 0.002 0.005 5.343 0.011 0.999
0.490–0.516 (1.9%) 5.28–5.40 (0.1%)
FatKA 0.511 0.001 0.005 5.34 0.010 0.999
0.498–0.525 5.27–5.40
GlandFL 0.718 0.002 0.013 5.155 0.013 0.998
0.683–0.753 (1.0%) 4.98–5.32 (1.0%)
GlandKS 0.711 0.010 0.012 5.118 0.020 0.999
0.677–0.745 4.95–5.28
Mo/Rh 29 kVp
FatFL 0.495 0.002 0.004 5.47 0.011 0.999
0.482–0.507 (1.2%) 5.41–5.53 (0.20%)
FatKA 0.501 0.001 0.004 5.48 0.010 0.999
0.489–0.513 5.42–5.54
GlandFL 0.700 0.002 0.014 5.274 0.014 0.998
0.661–0.739 (1.2%) 5.08–5.46 (0.20%)
GlandKS 0.692 0.010 0.013 5.263 0.020 0.998
0.655–0.729 5.08–5.44
Rh/Rh 30 kVp
FatFL 0.442 0.001 0.002 5.648 0.010 0.999
0.435–0.449 (0.21%) 5.61–5.68 (1.1%)
FatKA 0.443 0.001 0.002 5.712 0.010 0.999
0.434–0.451 5.66–5.75
GlandFL 0.644 0.002 0.010 5.557 0.010 0.999
0.621–0.666 (2.4%) 5.45–5.66 (1.0%)
GlandKS 0.629 0.005 0.010 5.593 0.014 0.999
0.609–0.648 5.49–5.69BioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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ment is an indication that attenuation coefficients are
characteristic quantities that may be saved or used as
known quantities. On the other hand, intercept values are
weak functions of the FFDM system. Assuming that the x-
ray tube outputs are similar, differences in the intercepts
may be due to variation within the detector/exposure
response. To explore this hypothesis, the open detector
response curves were generated for each system for the 26
kVp – Mo/Mo settings with methods described previously
[8] and briefly in the Methods Section (see normalization
discussion). Table 9 shows the slope and intercepts distri-
bution values for both systems (sectored analysis). The V
response for the KS system is about 1.6 (ratio of the
slopes) that of the FL system. The KS detector saturates
near 60 mAs, whereas the FL system saturates slightly
below 100 mAs  for this example. Intercept confidence
intervals both span zero but the KS width is much wider
than the FL width (about 114 in comparison with 451).
The work shows that there is relatively little spatial varia-
tion in the two regression parameters for a given location.
The choice of sector size will require further analysis to
determine the optimal size because it influences the vari-
ation. Without a clinical endpoint comparison (cancer/no
cancer patients), the appropriate spatial resolution of the
mapping cannot be determined. The optimal resolution
will be determined by its ability to assign breast cancer
risk after accruing sufficient patient data. Likewise, the
normalization work further demonstrates that when the
voltage setting and target/filter are held constant, only two
calibration curves are necessary, which permits a consid-
erable reduction of mAs calibration data collection (sam-
pling). Numerical evidence developed in the Appendix
shows that the map is well approximated as linear, which
is supported by experimental PG analysis. Moreover, the
calibration map generated by the calibration curve param-
eters is in close agreement with the measured values
obtained from the surrogate composite phantom imag-
ing, which is another indication that these FFDM systems
provide a quantitative output. As the PG external variation
analysis showed, intercepts are source of uncertainty in
the map. A similar argument would apply to a given sys-
tem if the system drifts in time relative to the calibration
curves. If the regression parameters are stable over time
and the intercept variation proves acceptable, the work
suggests that calibration parameters determined on a
given GE-FFDM system will apply to other similar systems
without the need for additional phantom imaging if the
variation estimated here is acceptable. To the best of our
Table 4: Effective attenuation coefficient comparisons. This 
shows the numerically derived attenuation coefficients, µT, the 
associated regression variation, ∆, and R2 values for the Mo/Mo, 
Mo/Rh, and Rh/Rh configurations for the same voltage settings 
(kVp) used for the phantom imaging. Attenuation coefficient 
confidence intervals are cited beneath the respective values. The 
<µ > column gives the averaged FL + KS measured attenuation 
coefficients for the respective tissue types. Percent differences 
between < µ > and µT are listed parenthetically next to the 
respective µT values. Other formatting is the same used above.
Mo/Mo µT ∆ R2 <µ >
Fat26 0.595 (2.8) 0.010 0.999 0.578
0.575–0.613
Gland26 0.871 (4.1) 0.020 0.998 0.835
0.818–0.923
Fat27 0.585 (2.9) 0.010 0.999 0.565
0.562–0.604
Gland27 0.836 (3.4) 0.021 0.997 0.807
0.777–0.894
Mo/Rh
Fat28 0.529 (4.0) 0.010 0.999 0.508
0.511–0.547
Gland28 0.764 (6.8) 0.014 0.998 0.713
0.772–0.807
Fat29 0.516 (3.8) 0.010 0.999 0.498
0.498–0.535
Gland29 0.735 (5.3) 0.020 0.998 0.696
0.690–0.779
Rh/Rh
Fat30 0.462 (4.3) 0.010 0.999 0.442
0.448–0.476
Gland30 0.675 (5.7) 0.010 0.999 0.636
0.647–0.703
Table 5: Normalization regression parameters. This gives the logarithmic response curve fitted parameter Molybdenum/Molybdenum 
(Mo/Mo) distribution quantities for both tissue types using the beam-current readout normalization (mAs). Acquisition mAs system 
values are indicated by the subscript of the left column entries.
Mo/Mo 26 kVp µσ ∆ l σl R2
Fat160 0.568 0.002 0.005 5.054 0.01 0.999
0.550–0.586 4.97–5.13
Fat110 0.569 0.002 0.006 5.058 0.010 0.999
0.549–0.590 4.97–5.14
Gland160 0.827 0.002 0.016 4.851 0.010 0.998
0.777–0.878 4.63–5.07
Gland200 0.826 0.002 0.015 4.853 0.010 0.998
0.777–0.875 4.64–5.06BioMedical Engineering OnLine 2008, 7:13 http://www.biomedical-engineering-online.com/content/7/1/13
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knowledge, the calibration values presented here are not
yet available in the public domain. This analysis was lim-
ited to two like systems due to availability. However, the
calibration quantities presented here may serve as refer-
ence for comparisons of related work in the field imple-
mented on other FFDM systems or can be used in
calibration research performed at other sites without addi-
tional imaging. These findings extend the previous work
[8,13] by demonstrating the relationship between the cal-
ibration map, the measured calibration points, and the
associated uncertainty.
5. Conclusion
Data used for this study is insufficient to assess the natural
serial variation in the regression parameters. Longer term
goals are to compare the inter/intra serial uncertainty with
this BL data. Control measures from the BL data have been
sampled on a biweekly basis since October 2007. Future
work will use this serial data to determine the serial varia-
tion and its impact on the calibration procedure when
assigning breast cancer risk to patient data. If the calibra-
tion approach is serially stable in the forward direction, it
implies that data collected previously can be calibrated. It
is often thought that FFDM data does not suffer from the
same technical difficulties associated with film data due to
varying response curves for example. This assumption
may be generally true but will require validation for quan-
titative calibration type measurements.
Ideally, generating calibration curves for all possible
acquisition techniques should produce the most accurate
data normalization, which is obviously not practical.
Thus, some form of interpolation is necessary. In part, the
longer term aim of this work is to minimize the amount
of a priori collected calibration data while maintaining
accurate standardization. Showing that the effective atten-
uation coefficients are characteristic quantities and dem-
onstrating the mAs normalization represent incremental
steps in this direction. The non-specialty center calibra-
tion application acceptance (or usage) may be enhanced
if the calibration data collection is minimized. In analo-
gous fashion, future work includes minimizing the
number of sample points in the voltage setting space. The
guiding principle is that if the calibration requires mini-
mal experimental effort, it may gain wider usage in the
future.
Percent glandular map individual sector example for the Mo/ Mo – 26 kVp settings Figure 6
Percent glandular map individual sector example for 
the Mo/Mo – 26 kVp settings. The (logarithmic response 
= z, theoretical percent glandular composition) ordered pairs 
are represented by diamonds, and the (z, regression fitted 
value) ordered pairs are represented by a solid line. Absolute 
difference between the known and fitted values was 1.7% for 
all points. This corresponds with the map shown in Fig. 5.



























Numerically derived percent glandular map Figure 5
Numerically derived percent glandular map. This cor-
responds to the example shown in The regression line is 
solid and numerically generated points are diamonds (see 
Appendix). In this case R2 = 0.999, which shows the map is 
well approximated as linear.
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Appendix
A. 1 Error propagation
Explicit calculation for Eq. (8) is derived using f = M(µg,
µf, lg, lf)z + B(µg, µf, lg, lf), where z is an arbitrary LR meas-
urement with f = PG and LR = µt + l, which is a modified
form of Eq. (1). The following substitutions are also used
G = [(µg + µf)T + lg + lf]
and
H = [(µg - µf)T + (lg - lf)].
Taking partial derivatives of f with respect to each of the
four parameters and z gives
and
These five partial derivative expressions were used to eval-
uate Eqs. (7–8).
A. 2 Calibration map analysis
Numerical methods, idealizations, abbreviations, and
quantities used previously [8] will be used to show the
map is approximately linear. The normalized energy pho-
ton distribution is given by p(ε). The response for com-
posite structure of T = total height corresponding to t1 cm
of glandular tissue with ∆t = T-t1 cm of fatty tissue is given
by
z' = ∫p(ε)exp[-µg(ε)t1 - µf(ε)∆t]dε.
Attenuation coefficients are implicit functions of the x-ray
energy (see previous work for details). The known PG =

































































Table 6: Percent glandular map parameters. The percent glandular row shows distribution quantities for the Molybdenum/
Molybdenum (Mo/Mo) map determined with surrogate mixture phantom imaging. The PG160 row gives M and B calculated with Eq. (7) 
using the 160 mAs regression parameters from Table 5 with Eq. (6).
Mo/Mo 26 kVp M σM ∆ B σB R2
PG -57.86 0.31 1.15 94.45 0.77 0.998
-61.5 – -54.2 90.7–98.2
PG160 -57.07 / / 93.76 / /
Table 7: Estimated uncertainties for the Molybdenum/
Molybdenum example.
Mo/Mo 26 kVp ∆µg ∆lg ∆µf ∆lf ∆LR
external 0.01 0.130 0.01 0.140 0.15
internal 0.002 0.01 .002 0.01 0.012
Table 8: Percent glandular map absolute % variation. This shows 
the individual external error (top) and internal error (bottom) 
components for the Molybdenum/Molybdenum – 26 kVp map 
output for each mixture. Totals follow from Eq. (8). The last two 
rows list the field of view average and standard deviation for 
each composition.
PG external variation 0 16.6 50 83.3 100
n1 0.02 0.30 0.89 1.42 1.68
n2 3.8 3.1 1.8 0.64 0.07
n3 0.07 1.3 3.7 6.0 7.0
n4 7.4 6.0 3.5 1.3 0.14
n5 0.78 0.95 1.42 1.9 2.3
total external variation 8.4 7.0 5.7 6.6 7.6
Internal variation
n1 0.02 0.03 0.89 1.42 1.68
n2 3.80 3.10 1.81 0.64 0.08
n3 0.0 0.10 0.30 0.47 0.56
n4 0.58 0.47 0.30 0.10 0.01
n5 0.78 0.95 1.42 1.90 2.3
total internal variation 3.9 3.3 2.5 2.5 2.9
<z> 1.659 1.329 0.735 0.188 -0.738
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kVp – Mo/Mo simulated spectra for t1 = [1,2,3,4,5,6] cm
with the known PG = [16.6, 33.3, 50.0, 66.6, 83.3, 100.0],
gives R2 = 0.999 when applying regression analysis to the
ordered pairs: [ln(z'), PG]. The fitted line is shown in Fig.
5 for this example (regression line parameters as irrelevant
here). Linear agreement is important because it validates
the map form. The same analysis was carried out for T =
[2,3,6] cm for all filter/target combinations and kVp val-
ues used for the phantom imaging based LR analysis with
same the t1 values and PG sample points used to generate
Fig. 6. For all combinations, the results were similar with
R2 = 0.999, which validates the use of Eq. (5).
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Table 9: Detector response parameter comparison. This shows the detector response regression parameters (distribution quantities) 
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FL 183.2 (1.22) 180.9–185.4 58.8 (12.1) -55.3–173.1 0.999
KS 300.0 (3.36) 286.5–313.5 256.1 (14.2) -195.6–707.8 0.999